December 22, 2015 - The U.S. Food and Drug Administration has cleared the Zoll LifeVest Wearable Cardioverter Defibrillator, Models 3000, 3100, and 4000, for the additional indication treating pediatric patients 

December 22, 2015 — The American College of Cardiology (ACC) has launched a new Society of Thoracic Surgeons (STS)/ACC Transcatheter Aortic Valve Replacement (TAVR) In-Hospital Mortality Risk App and an extensively overhauled the ACC AnticoagEvaluator App, bolstering its expansive Clinical App Collection. With these new and improved apps, the ACC continues to diversify the clinical content and decision support it offers clinicians in the mobile space.

At the 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Siemens displayed new offerings for teamplay, a cloud-based network that helps link hospitals and healthcare experts, enabling them to exchange data and pool their knowledge.

December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors contributing to heart failure, obstructive sleep apnea on atrial fibrillation recurrence and full body MRI in patients with an implantable cardioverter defibrillator (ICD) were among the top accessed research studies in the five journals published by the American College of Cardiology.

December 22, 2015 — Biotronik received U.S. Food and Drug Administration (FDA) approval for use of its latest family of implantable cardioverter defibrillator (ICD) systems with magnetic resonance imaging (MRI) scans. Biotronik ProMRI technology allows patients with approved device systems to have 1.5 Tesla MRI scans without an exclusion zone. ICD patients will have expanded access to MRI diagnostic scans, which can be critical for diagnosing conditions such as stroke, brain and cardiac tumors or orthopedic injuries.
 

Controversies and Updates in Vascular Surgery

Siemens Healthcare’s approach to delivering dose-neutral dual energy images obtained on Somatom computed tomography (CT) scanners using TwinBeam Dual Energy technology is now commercially available on the Somatom Definition Edge and Somatom Definition AS CT systems.

Complex Cardiovascular Catheter Therapeutics (C3)

C3 has been specifically designed for physicians who specialize in interventional cardiology, vascular surgery, and interventional radiology, as well as fellows, residents, and other healthcare professionals interested in atherosclerotic cardiovascular disease. C3 offers presentations and debates with expert global faculty, live and pre-recorded cases, industry-sponsored and supported symposia, exhibit booths and simulators, poster sessions, case presentations and hands-on workshops.

Subscribe Now